WELL Health Technologies Corp.
TSX:WELL.TOMedical - Care Facilities
+$0.02 today
- Market cap
- $947.00M
- Beta
- 1.33
- P/E (TTM)
- 41.6
- EPS (TTM)
- $0.11
Volume 2.80M
Average 1.62M
Returns on capital
WELL Health Technologies Corp. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-5.8%
avg 56.9%
ROIC
5.1%
avg -216.9%
ROA
-2.4%
avg -126.4%
Analysis
ROIC is currently the strongest return metric at 5.1% versus its period average of -216.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Hamed Shahbazi | Founder, Chairman & Chief Executive Officer | CAD 950K | 51 | — | — |
Dina Sergi | Chief Executive Officer of WELL Diagnostic Centres | CAD 679.26K | — | — | — |
Bill Crawford | Chief Financial Officer of CRH | CAD 573.1K | — | — | — |
Evelyn Louise Sutherland FCPA | Chief Financial Officer | CAD 270K | 52 | — | — |
Eva Fong | Chief Financial Officer | CAD 270K | — | — | — |
Derek Clark | Chief Operating Officer | CAD 265K | — | — | — |
Kaytek Przybylski | Chief Digital & Information Officer | — | — | — | — |
Loreto Grimaldi | Chief Legal Officer | — | 55 | — | — |
Pardeep S. Sangha | Vice President of Corporate Strategy & Investor Relations | — | — | — | — |
Ric Leong | Chief Accounting Officer | — | — | — | — |
Shane Joseph Sabatino | Chief People Officer | — | — | — | — |
Chris Ericksen | Senior Vice President of Strategic Partnerships & Marketing | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
No open-market purchases or sales in the last 12 months.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | +35.0% | +9.4% (3yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | +69.3% | +134.0% (3yr)2 analysts |
Analysis
Recent growth has been strongest in EBIT at +69.3% over three years. Forward estimates point to EBIT at +134.0% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does WELL Health Technologies Corp. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about WELL.TO's management, answered from reported figures.
Who manages WELL.TO?
WELL Health Technologies Corp. (WELL.TO) lists 12 active executives. The top listed executive is Hamed Shahbazi, Founder, Chairman & Chief Executive Officer.
Continue the stock analysis
Jump to another research area for this company.